Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: contrast agent

February 16, 2021 CD as API / CD derivatives

Gd(3+) Complexes Conjugated to Cyclodextrins

In the search for improvement in the properties of gadolinium-based contrast agents, cyclodextrins (CDs) are interesting hydrophilic scaffolds with high

Continue reading

November 12, 2019 Drug delivery / Pharma applications

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated presented positive results from a Phase 1 clinical trial of its Captisol-enabled (CE) Iohexol program at ASN

Continue reading

July 17, 2019 Pharma applications

Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol

Continue reading

May 3, 2019 Pharma applications

Enrollment completed of Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated announced completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol

Continue reading

Recent Posts

  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (67)
  • CD as API (347)
  • CD derivatives (411)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (793)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (223)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (401)
  • Other industrial use (106)
  • Pharma applications (1,186)
  • Supramolecular systems (40)
  • Uncategorized (149)

Top Posts

  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease
  • How air fresheners work?
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...